Filter Results:
(1,202)
Show Results For
- All HBS Web
(1,202)
- People (5)
- News (334)
- Research (708)
- Events (1)
- Multimedia (17)
- Faculty Publications (456)
Show Results For
- All HBS Web
(1,202)
- People (5)
- News (334)
- Research (708)
- Events (1)
- Multimedia (17)
- Faculty Publications (456)
- 24 Oct 2023
- HBS Case
From P.T. Barnum to Mary Kay: Lessons From 5 Leaders Who Changed the World
I knew that in order to get something, I had to give up something else.” Her mother worked at a restaurant to support them, and Ash would call her for instructions on cooking and other household tasks. Her mother patiently motivated her... View Details
Keywords: by Avery Forman
- Web
Placement - Doctoral
2021 Placement: Harvard Medical School, Post-Doctoral fellow (2021-2024); University of Pennsylvania, Perelman School of Medicine, Assistant Professor (2024-) Dissertation: The Patient Role in Health Care... View Details
- January–February 2021
- Article
Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses
By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
As pressure mounts on the Food and Drug Administration (FDA) to speed its review process for novel devices, and budgetary pressures further strain its resources, the critical role of guidance documents in assuring consistent, rigorous, and scientifically grounded... View Details
Keywords: Medical Devices; FDA; Health Care and Treatment; Government Administration; Information; Standards
Weitzman, Rachel E., Ariel Dora Stern, and Daniel B. Kramer. "Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses." American Journal of Therapeutics 28, no. 1 (January–February 2021).
- April 2008
- Case
Ophthalmic Consultants of Boston and Dr. Bradford J. Shingleton (2004)
By: H. Kent Bowen and Marcelo Pancotto
Dr. Bradford Shingleton has developed some of the highest quality eye surgery techniques in the industry. He involves his nurses and technicians in creating a surgical service that is constantly improving. The case has many details about how Dr. Shingleton works with... View Details
Keywords: Health Care and Treatment; Independent Innovation and Invention; Service Operations; Performance Productivity; Practice; Problems and Challenges; Health Industry; Boston
Bowen, H. Kent, and Marcelo Pancotto. "Ophthalmic Consultants of Boston and Dr. Bradford J. Shingleton (2004)." Harvard Business School Case 608-151, April 2008.
- Research Summary
Health-care Applications
Active postmarketing drug surveillance. There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details
- Web
Publications - Institute For Strategy And Competitiveness
Feeley, M.D.f, Neema Navai, M.D. Objectives: Patients undergoing radical cystectomy represent a particularly resource-intensive patient population. Time-driven activity based costing (TDABC) assigns time to... View Details
- February 2025
- Case
Abiomed: A Change of Heart
By: Satish Tadikonda, Faith Robertson and William Marks
After acquiring Impella CardioSystems AG in May 2005, Abiomed Inc., a company focused on cardiac care, ran into a dilemma. Its Impella 2.5 device was approved for use in the European Union, but CEO Michael Minogue had seemingly bet the company's future on the ability... View Details
Keywords: Mergers and Acquisitions; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Business and Government Relations; Medical Devices and Supplies Industry; European Union; United States
Tadikonda, Satish, Faith Robertson, and William Marks. "Abiomed: A Change of Heart." Harvard Business School Case 825-011, February 2025.
- May 2025
- Teaching Note
The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation
By: Tsedal Neeley
Teaching Note for HBS Case No. 425-720. Florian Hillen, co-founder and CEO of VideaHealth, a startup using artificial intelligence (AI) to detect dental conditions on x-rays, spent the early years of his company laying the groundwork for an AI factory. This AI factory,... View Details
- 03 Aug 2010
- First Look
First Look: August 3
employees are more likely to speak up and offer solutions when organizations launch information campaigns to promote process improvement and when managers engage in process-improvement activities themselves. We test our hypotheses in the health View Details
Keywords: Martha Lagace
- January 2025
- Supplement
The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation (B)
By: Tsedal Neeley, Levi Stroud, Ruth Page and Dave Habeeb
Pre-abstract:
This multimedia case should be assigned to students in advance of class. Instructors should consider the timing of making the (B) Case videos available to students, as they may reveal key case details.
Abstract: Florian Hillen, co-founder... View Details
Abstract: Florian Hillen, co-founder... View Details
Keywords: Diagnostics; Organization Design; Change Management; Disruption; Transformation; Health Care and Treatment; AI and Machine Learning; Technology Adoption; Technological Innovation; Management Style; Organizational Culture; Success; Technology Industry; Health Industry; United States
Neeley, Tsedal, Levi Stroud, Ruth Page, and Dave Habeeb. "The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation (B)." Harvard Business School Multimedia/Video Supplement 425-721, January 2025.
- January 2025
- Case
The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation (A)
By: Tsedal Neeley, Levi Stroud, Ruth Page and Dave Habeeb
Pre-abstract:
This multimedia case should be assigned to students in advance of class. Instructors should consider the timing of making the (B) Case videos available to students, as they may reveal key case details.
Abstract: Florian Hillen, co-founder... View Details
Abstract: Florian Hillen, co-founder... View Details
Keywords: Diagnostics; Organization Design; Change Management; Disruption; Transformation; Health Care and Treatment; AI and Machine Learning; Technology Adoption; Technological Innovation; Management Style; Organizational Culture; Success; Technology Industry; Health Industry; United States
Neeley, Tsedal, Levi Stroud, Ruth Page, and Dave Habeeb. "The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation (A)." Harvard Business School Multimedia/Video Case 425-720, January 2025.
- 14 Mar 2017
- First Look
First Look at New Research, March 14
highlighting inconsistencies in the care of RA patients in England. In particular, the company considered the current use of biologic medications to treat RA in England as well as how the introduction of... View Details
Keywords: Sean Silverthorne
- May 2021
- Case
Inclusive Innovation at Mass General Brigham
By: Katherine Baldiga Coffman and Olivia Hull
Massachusetts General Brigham (MGB) Chief Innovation Officer Christopher Coburn had overseen a period of exciting transformation and growth in healthcare innovation at MGB. In November 2019, the health system was the largest recipient of National Institutes of Health... View Details
Keywords: Inclusion; Innovation; Invention; Gender; Business Startups; Investment Funds; Private Equity; Health Care and Treatment; Innovation Strategy; Technological Innovation; Intellectual Property; Copyright; Patents; Research; Research and Development; Diversification; Technology; Health Industry; Massachusetts; Boston
Coffman, Katherine Baldiga, and Olivia Hull. "Inclusive Innovation at Mass General Brigham." Harvard Business School Case 921-006, May 2021.
- Article
Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users
By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details
Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States
Stern, Ariel Dora, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup, and Ernst R. Berndt. "Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users." Health Affairs 40, no. 6 (June 2021): 989–999.
- April 2017
- Supplement
Imprimis (C)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details
Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (C)." Harvard Business School Supplement 717-497, April 2017.
- Web
Biography - Institute For Strategy And Competitiveness
devoted considerable attention to the economics of health care, with a focus on building the intellectual framework for realigning the delivery of health care to maximize value to patients (patient health... View Details
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States
Ofek, Elie, and Polly Ross Ribatt. "Tengion: Bringing Regenerative Medicine to Life." Harvard Business School Case 510-031, October 2009. (Revised August 2014.)
- 01 Mar 2024
- News
Vital Signs
day. An abbreviation of “demonstrating diagnostics,” DemDx is a software platform with embedded AI technology that guides health care providers through all the necessary questions in a patient examination to... View Details
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
nearby Borders bookstore revealed a three-year life expectancy with no available treatment options. And trying to navigate the complexities of the American health care system—bouncing from pathologist to a medical oncologist to... View Details
- 07 May 2009
- Working Paper Summaries